My Research – Session 4: Risk Predictions – Statistical versus Machine learning methods – Wednesday May 12th at 7pm!

Session 4 (Wednesday 12th May at 19:00 GMT) –  CLICK HERE to REGISTER

 

We would like to invite you to join our monthly ‘My Research’ sessions. These sessions are delivered by members that have undertaken an audit or evaluation. They will spend 10 minutes describing their career pathway and the next 10 minutes about the research methods that they used. There will be time for detailed questions following the talk. These sessions will enable members to learn about quantitative and qualitative methods and the learning may guide and help you in your future projects. We also hope that this will be a good opportunity to learn about different career pathways in cancer pharmacy.

 

The session will be delivered by: Pinkie Chambers and Bruce Burnett

 

Biography (Pinkie Chambers) – Pinkie is a clinical academic at University College London (UCL) and University College NHS Foundation Trust.   Her research activities are all around improving the delivery of systemic anticancer treatments and has experience of using large datasets and prognostic modelling techniques. She has held various roles within cancer including developing new clinic pharmacy services at UCLH and Lead Pharmacist for London Cancer. She the current co-chair of the UK Chemotherapy board , joint audit, and research lead for BOPA and chair of The Chemotherapy Expert Reference group at the NCL cancer alliance as well as a member of the Heath Foundation Q Community.

 

 

 

 

 

Biography (Bruce Burnett) – My name is Bruce Burnett and I am a final year PhD student at Swansea University. I have a Master of Medical Sciences in Clinical Oncology and a Batchelor of Science degree in Pharmacy with a postgraduate certificate in Supplementary Prescribing.  My current research relates to the prediction of colorectal cancer from routinely collected health and social data using machine learning techniques. Previously I was an oncology pharmacist with over 15 years experience and an interest in head and neck and upper GI cancers. I am also a guest lecturer at Coventry University on the topic of biopharmaceuticals in the management of cancer.

 

 

 

 

 

 

 

 

 

Please Note:

-Webinars will start at 19:00 GMT and will last about 30 minutes to 1 hour

-The Zoom link for the webinar will be sent on the day of the event around 17:30pm (if you would like the link before this time please email [email protected])

-Webinars are FREE to access for BOPA Paid Members

-Webinars will be recorded and appear in the BOPA eLearning section of the website via this link: https://www.bopa.org.uk/course-category/audit-and-research/

-Webinars will aim to be on a monthly basis

 

Pinkie, Bastiaan and Alkesh
BOPA Audit & Research and Education &Training Sub-Committee Chairs

 

Latest News

By Joseph Williams on 8th June 2026

BOPA and Pharmaceutical Journal (PJ) Collaboration – Advanced therapy medicinal products: a tsunami in clinical medicine (By BOPA Member – Nisha Shaunak)

This article is brought to you as part of a collaboration with the Pharmaceutical Journal (PJ). The views expressed in this article are those of the author and are not…

Read article
By BOPA E&T Subcommittee on 4th June 2026

SAVE THE DATE: BOPA Introduction to Cancer Course, London, September 2026 – Registration opens soon!

The popular Introduction to Cancer Course is coming to London in September 2026 The BOPA Introduction to Cancer Course 2026 WHEN: Thursday 17th & Friday 18th September 2026 WHERE: University College Hospital,…

Read article
By Macmillan Cancer Support on 4th June 2026

Cancer Information Development team at Macmillan Cancer Support

Dear BOPA members, The Cancer Information Development team at Macmillan Cancer Support would like to make you aware of a couple of new cancer treatment information pages on our website:…

Read article
By Clayton Wong on 1st June 2026

Launch of Bespoke Health Technology Assessment Course

Bespoke CPD Course on Health Technology Assessment (HTA)    We are delighted to see the launch of the BOPA Health Technology Assessment (HTA) course, which represents an important step forward in supporting the cancer pharmacy workforce…

Read article